Celebrating a 'decade of discovery' since the Human Genome Project
New project launched to sequence 10,000 genomes in three years
Leading scientists from the public efforts to map the human genome today celebrate a decade of discovery since the announcement of the first draft 10 years ago. And in a dramatic sign of the rapid progress being made, they launched the UK 10,000 Genomes Project.
On 26 June 2000, President Bill Clinton and Prime Minister Tony Blair announced the completion of the first draft of the human genome at a joint press conference. The draft had taken 10 years to complete, the result of collaboration from laboratories in China, France, Germany, Japan, UK and the USA.
Today, key players involved in the public side of the collaboration discussed the impact of the Human Genome Project at the launch of the Science Museum’s Who am I? gallery. They included Nobel Laureate Sir John Sulston and Dr Francis S. Collins, Director of the National Institutes of Health, both of whom took part in the original announcement in 2000. Today they were joined by Sir Mark Walport, Director of the Wellcome Trust, and Professor Mike Stratton, Director of Wellcome Trust Sanger Institute.
The Wellcome Trust funded one-third of the Project and was instrumental in ensuring that the data obtained was kept in the public domain.
“We have had an extraordinary decade of discovery since the completion of the draft sequence of the human genome. Almost every week scientists around the world make important discoveries of how variation in the human genome causes variation in health and disease. We have learnt much about human origins and migration – and about our close relationships to other species. But most of all we have learnt about the extraordinary complexity of the human body and about what makes us unique as individuals. The sequence of the human genome will continue to inspire scientists with ideas and questions for many years to come.”
Sir Mark Walport Current Director of the Wellcome Trust
“A key decision in the project, and one which has had a lasting legacy in science, was to release all data quickly as we went along. As a result not only the human genome but many other genomes as well are freely available in the public domain, facilitating comparison and analysis of these immensely complex pieces of information. The Human Genome Project is widely regarded as a model for open science.”
Sir John Sulston who was Director of the Wellcome Trust Sanger Institute from 1992 to 2000 and led the UK’s efforts in the Human Genome Project
“The First Law of Technology states that truly transformational technology will have its immediate consequences overestimated and its long-term consequences underestimated. Reflecting back on the announcement of the draft sequence in 2000 I think that law is coming true for the Human Genome Project. After a decade of hard work in the basic science of genomics, the health benefits are beginning to arrive. When I look across medical research – whether it is for cancer or heart disease or diabetes – I see researchers using the expanding array of tools that have arisen from the Human Genome Project. The leading edge of advances in diagnosis, prevention, and treatment has arrived, though the full flowering of genomic medicine still lies ahead.”
Dr Francis S Collins, Director of the National Institutes of Health and former leader of the US component of the Human Genome Project
The UK 10,000 Genomes Project
Ten years on from the announcement of the first draft, Professor Mike Stratton, now Director of the Wellcome Trust Sanger Institute, announced the launch of the UK 10,000 Genomes Project.
“Over the past decade, we have found hundreds of common variants that each make a small difference to many diseases but we still have to explain much of the genetic basis of most diseases. One promising source of additional genetic contribution is in rarer variants which each confer greater risks of disease.
“It took 13 years to sequence the first genome. Now we sequence several human genomes every few days. The UK 10,000 Genomes Project will involve a collaboration with leading UK medical geneticists to sequence the genomes of ten thousand individuals in a search for these rarer variants and will take advantage of these technical advances to explore exhaustively this part of the genetic landscape and the contribution it makes to health and disease.”
Professor Mike Stratton Director of the Wellcome Trust Sanger Institute
Science Museum asks Who am I?
Opening to the public on 26 June 2010 the Science Museum’s new Who am I? gallery presents the latest brain science, genetics and genomics research through a mix of fascinating objects, hands on multimedia exhibits and new contemporary art works. Visitors to this fascinating exhibition will be able to explore the science of identity and find out what makes each of us unique. Entrance to Who am I? is free.
For 100 years the Science Museum has been world-renowned for its historic collection, remarkable galleries and inspirational exhibitions. With around 15,000 objects on public display, the Science Museum’s collections form an enduring record of scientific, technological and medical change from the past few centuries. Aiming to be the best place in the world for people to enjoy science, the Science Museum makes sense of the science that shapes our lives, sparking curiosity, releasing creativity and changing the future by engaging people of all generations and backgrounds in science engineering, medicine, technology, design and enterprise. In 2008/09 the Science Museum was proud to have been awarded the Gold Award for Visitor Attraction of the Year by Visit London and a Silver Award for Large Visitor Attraction of the Year by Enjoy England.
The Wellcome Trust Sanger Institute, which receives the majority of its funding from the Wellcome Trust, was founded in 1992. The Institute is responsible for the completion of the sequence of approximately one-third of the human genome as well as genomes of model organisms and more than 90 pathogen genomes. In October 2006, new funding was awarded by the Wellcome Trust to exploit the wealth of genome data now available to answer important questions about health and disease.
The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. We support the brightest minds in biomedical research and the medical humanities. Our breadth of support includes public engagement, education and the application of research to improve health. We are independent of both political and commercial interests.
21 Feb 2024
Butterfly and moth genomes mostly unchanged despite 250 million years of evolution
Comparison of over 200 high-quality butterfly and moth genomes reveals key insights into their biology, evolution and diversification over the last ...
14 Feb 2024
Key genes linked to DNA damage and human disease uncovered
Scientists unveil 145 genes vital for genome health, and possible strategies to curb progression of human genomic disorders